Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

A Northwestern Medicine study has revealed a previously unknown connection between two fundamental cellular processes, ...

A group of scientists, including Sergey Frolov, professor of physics at the University of Pittsburgh, and co-authors from ...

Researchers at The Institute of Cancer Research, London identified the CIP2A–TOPBP1 complex as a master regulator of DNA ...

Newly sequenced Native genomes showcase a wealth of surprises, from previously unknown populations to unique high-altitude adaptations.

ELF3 axis enables luminal progenitor transformation in BRCA1-deficient breast cancer by reducing genomic instability and promoting progenitor identity.

Danish researchers believe that everyone should monitor their blood folate levels. They argue that a deficiency in folic acid ...

Fraunhofer researchers, together with agricultural partners, have developed the PhenoTruck®, a mobile laboratory designed to enable rapid, on-site detection of climate-driven pests threatening fruit ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

After nearly ten years of internal research and commercialization planning, Atlas Data Storage, a spin-off built on Twist ...

Study uncovers key insights about how a new class of antiviral drugs works. Cryo-EM images showed the drugs bound to herpes simplex virus (HSV) protein at nearly atomic detail, while optical tweezers ...